EVENTS
94th EAS Congress
The ABCardionostics coordinator team will attend the 94th European Atherosclerosis Society (EAS) Congress. As one of the leading international meetings in the field, the congress brings together researchers and clinicians to discuss the latest advances in atherosclerosis and vascular disease.
ABCardionostics will contribute to the congress with two poster presentations by Valentine Michel (PhD, CRMSB, Université de Bordeaux) and Yaëlle Guiberteau (PhD, Toulouse Biotechnology Institute), highlighting recent developments from the project.
To learn more: https://eas-congress.com/2026/congress/general-information/
24-27 May 2026 Athens, Greece
NSFA Congress 2026
The ABCardionostics coordinator team (CRMSB, Université de Bordeaux) will attend the 20th Congress of the Nouvelle Société Francophone d’Athérosclérose (NSFA) in Biarritz, France, from 24-26 June 2026. The congress offers an important forum for scientific exchange around emerging approaches in cardiovascular research.
To learn more: https://www.nsfa.asso.fr/congres/congres-nsfa-2026/#presentation
24-26 June 2026 Biarritz, France
ABCardionostics General Assembly
The ABCardionostics consortium will gather in person for its second General Assembly in Maastricht on 6–7 October, kindly hosted by our partner MUMC. Taking place at month 19 of the project, this meeting is a key milestone, offering the consortium the opportunity to exchange results, review progress, and plan the next steps together.
Date: 6-7 October 2025
Antibody Technologies and Therapeutics Conference
From 15–18 September 2025, the Antibody Technologies and Therapeutics Conference will take place at the Monash Facility in Tuscany, Italy. Since 2015, this premier event has brought together a select group of up to 100 leading scientists from academia and industry to exchange on antibody engineering, structure and dynamics, and emerging therapeutic targets in inflammation, infection, oncology, and metabolic disease.
ABCardionostics coordinator Dr. Gisèle Clofent-Sanchez will contribute to the programme with a talk titled “Fully human antibodies for theranostic applications in atherosclerosis.”
More info: https://www.monash.edu/researchinfrastructure/madp
15-18 September 2025 Prato, Italy
CNRS Section 28 Congress in Reims
The CNRS Section 28 Congress in Reims features two half-days of high-level invited lectures, oral presentations, and poster sessions. The event will cover multidisciplinary themes including pharmacology, health technologies, biotherapies, biomedical imaging, precision medicine, and industrial innovation.
To learn more (FR version only): https://congress28-2025.sciencesconf.org/
5-6 June 2025 Reims, France
EAS 93d Congress
The 93rd EAS Congress, held in Glasgow from May 4-7, 2025, will feature the latest research in atherosclerosis and related vascular diseases. The event offers both in-person and virtual attendance, with a focus on interdisciplinary exchange between clinicians and researchers.
To learn more: https://eas-congress.com/2025/#
4-7 May 2025 Glasgow, UK
ABCardionostics General Assembly
The ABCardionostics consortium will come together for its General Assembly, a key milestone in the project’s timeline. This meeting will provide an opportunity for all partners to share results, review progress, and align on the next steps